Search Results - "Akerele, Toks"

Refine Results
  1. 1
  2. 2
  3. 3

    Treatment patterns and persistence rates with anti‐vascular endothelial growth factor treatment for diabetic macular oedema in the UK: A real‐world study by Peto, Tunde, Akerele, Toks, Sagkriotis, Alexandros, Zappacosta, Sofia, Clemens, Andreas, Chakravarthy, Usha

    Published in Diabetic medicine (01-04-2022)
    “…Introduction Anti‐vascular endothelial growth factors (anti‐VEGFs) are considered standard of care therapy for diabetic macular oedema (DME). This study…”
    Get full text
    Journal Article
  4. 4

    The Neovascular Age-Related Macular Degeneration Database: Multicenter Study of 92 976 Ranibizumab Injections

    Published in Ophthalmology (Rochester, Minn.) (01-05-2014)
    “…Purpose To study real-world ranibizumab therapy for treatment-naïve eyes with neovascular age-related macular degeneration (nAMD) and to benchmark standards of…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    VISUAL ACUITY IMPROVEMENT WHEN SWITCHING FROM RANIBIZUMAB TO AFLIBERCEPT IS NOT SUSTAINED by Lee, Cecilia S, Kim, Alisa J, Baughman, Douglas, Egan, Catherine, Bailey, Clare, Johnston, Robert L, Natha, Salim, Khan, Rehna, Brand, Christopher, Akerele, Toks, McKibbin, Martin, Downey, Louise, Al-Husainy, Saher, Lee, Aaron Y, Tufail, Adnan

    Published in Retina (Philadelphia, Pa.) (01-05-2018)
    “…To assess whether visual benefits exist in switching to aflibercept in patients who have been chronically treated with ranibizumab for neovascular age-related…”
    Get full text
    Journal Article
  15. 15

    The cost-effectiveness of initiating ranibizumab therapy in eyes with neovascular AMD with good vision: an economic model using real-world outcomes by Butt, Thomas, Lee, Aaron, Lee, Cecilia, Tufail, Adnan

    Published in BMJ open (05-05-2015)
    “…Objectives To evaluate the cost-effectiveness of immediate treatment with ranibizumab in patients with neovascular age-related macular degeneration (nAMD) with…”
    Get full text
    Journal Article
  16. 16

    Hinchingbrooke Hospital’s reply to “inadequate” rating on patient care by Hamilton, Suzanne

    Published in BMJ (Online) (20-01-2015)
    “…In the "friends and family test," 97% of patients recommend us. 2 We were in the top 20% of hospitals for patients rating our care "good" or "excellent" (94%…”
    Get full text
    Journal Article
  17. 17

    Ocular complications in heart, lung and heart-lung recipients by Akerele, Toks, Lightman, Susan

    Published in British journal of ophthalmology (01-03-2007)
    “…Aim: To prospectively assess ocular morbidity and the need for ocular screening in patients on long term, high dose immunosuppression for the maintenance of…”
    Get full text
    Journal Article
  18. 18

    Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy by Akerele, Toks, Galatowicz, Grazyna, Bunce, Catey, Calder, Virginia, Lynn, William A., Lightman, Susan

    Published in Clinical Immunology (01-11-2006)
    “…CD4+ and CD8+ lymphocyte cytokine production in patients with HIV/AIDS and Controls, in response to stimulation with phorbol-12-myristate-13-acetate (PMA) and…”
    Get full text
    Journal Article
  19. 19

    Topical versus peribulbar anesthesia, without sedation, for clear corneal phacoemulsification by Johnston, R L, Whitefield, L A, Giralt, J, Harrun, S, Akerele, T, Bryan, S J, Kayali, N, Claoué, C M

    Published in Journal of cataract and refractive surgery (01-03-1998)
    “…To investigate patient and surgeon acceptance of topical anesthesia as an alternative to peribulbar anesthesia for clear corneal phacoemulsification…”
    Get more information
    Journal Article
  20. 20